Type 1 diabetes advocacy group, T1 International, organized the rally, where people called on pharmaceutical companies like Eli Lilly to make insulin and other life-saving drugs more affordable.
One in four people with diabetes rations insulin because they can’t afford it, according to a study published in JAMA conducted by researchers from New Haven, Conn.-based Yale University
Read the full report here.
More articles on pharmacy:
California biotech files for bankruptcy
Ohio’s Medicaid director may give results of drug pricing report in front of oversight committee
Q2 brings smaller hikes to wholesale, net drug prices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.